We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · January 13, 2021

Effect of Empagliflozin on Exercise Ability and Symptoms in Patients With HF With or Without Type 2 Diabetes

European Heart Journal


Additional Info

European Heart Journal
Effect of Empagliflozin on Exercise Ability and Symptoms in Heart Failure Patients With Reduced and Preserved Ejection Fraction, With and Without Type 2 Diabetes
Eur Heart J 2020 Dec 22;[EPub Ahead of Print], WT Abraham, J Lindenfeld, P Ponikowski, P Agostoni, J Butler, AS Desai, G Filippatos, J Gniot, M Fu, L Gullestad, JG Howlett, SJ Nicholls, J Redon, I Schenkenberger, J Silva-Cardoso, S Störk, J Krzysztof Wranicz, G Savarese, M Brueckmann, W Jamal, M Nordaby, B Peil, I Ritter, A Ustyugova, C Zeller, A Salsali, SD Anker

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading